Get started
Author

Armina Shirangi

ORCID: 0000-0002-5306-5137
Observed ORCID: 0000-0002-5306-5137
OpenAlex ID: A5045498987
RETRACTED: Theranostic silk sericin/SPION nanoparticles for targeted delivery of ROR1 siRNA: Synthesis, characterization, diagnosis and anticancer effect on triple-negative breast cancer
2022 · Armina Shirangi, Fatemeh Mottaghitalab, et al. · International Journal of Biological Macromolecules · 41
Targeted delivery of doxorubicin by SP5-52 peptide conjugated exosome nanoparticles into lung tumor: An in vitro and in vivo study
2023 · Ayda Moradi, Armina Shirangi, et al. · Journal of Drug Delivery Science and Technology · 12
Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma
2023 · Seyed Reza Heydari, Mahnoush Samadi, et al. · Journal of Drug Delivery Science and Technology · 7
Nanotechnology-assisted lung cancer diagnosis: biomarkers and imaging
2025 · Sina Maskoukian, Ayda Moradi, et al. · Journal of Nanoparticle Research · 4
Recent trends in controlled drug delivery based on silk platforms
2024 · Armina Shirangi, Afrah Sepehr, et al. · Elsevier eBooks · 3
Retraction notice to “Theranostic silk sericin/SPION nanoparticles for targeted delivery of ROR1 siRNA: Synthesis, characterization, diagnosis and anticancer effect on triple-negative breast cancer” [Int. J. Biol. Macromol. 221 (2022) 604–612]
2026 · Armina Shirangi, Fatemeh Mottaghitalab, et al. · International Journal of Biological Macromolecules
PDF
List of contributors
2024 · Catarina M. Abreu, Prachi Agarwal, et al. · Elsevier eBooks
Works count: 7
Citation count: 67
H-index: 4
I10-index: 2
Year
Topic
Type